{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:01Z","timestamp":1792801861354,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["190510369725"],"award-info":[{"award-number":["190510369725"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["SR\/FST\/LS-I\/2017\/05"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2017\/05"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.lfs.2022.121352","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T07:11:31Z","timestamp":1672384291000},"page":"121352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target"],"prefix":"10.1016","volume":"314","author":[{"given":"Rohan","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhel","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.121352_bb0005","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1523\/JNEUROSCI.2121-13.2013","article-title":"Glial scar Borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury","volume":"33","author":"Wanner","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113309","article-title":"Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases","volume":"329","author":"Simmons","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cns.13378","article-title":"Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury","volume":"26","author":"Bonsack","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.lfs.2022.121352_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/neu.2013.3019","article-title":"Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0025","article-title":"Temporal dysfunction in traumatic brain injury patients: primary or secondary impairment?","volume":"12","author":"Mioni","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0030","first-page":"23","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Lee","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","article-title":"Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury","volume":"68","author":"McKee","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0045","first-page":"511","article-title":"Traumatic brain injury as a risk factor for Alzheimer\u2019s disease","volume":"75","author":"Jellinger","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.lfs.2022.121352_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.870060202","article-title":"Head trauma as a risk factor for Parkinson\u2019s disease","volume":"6","author":"Stern","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.lfs.2022.121352_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0706743716644953","article-title":"Knowing what we Don\u2019t know: long-term psychiatric outcomes following adult concussion in sports","volume":"61","author":"Finkbeiner","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.lfs.2022.121352_bb0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-150895","article-title":"Self-reported traumatic brain injury and mild cognitive impairment: increased risk and earlier age of diagnosis","volume":"51","author":"LoBue","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2022.121352_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/brain\/awx350","article-title":"Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model","volume":"141","author":"Tagge","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2022.121352_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1073858415585108","article-title":"From molecular circuit dysfunction to disease: case studies in epilepsy, traumatic brain injury, and Alzheimer\u2019s disease","volume":"22","author":"Dulla","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.lfs.2022.121352_bb0075","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"20","author":"Saatman","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-020-00924-7","article-title":"Biological links between traumatic brain injury and Parkinson\u2019s disease","volume":"8","author":"Delic","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2022.121352_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0090","first-page":"20","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Sastre","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0095","first-page":"30","article-title":"Microglia in the TBI brain: the good, the bad, and the dysregulated","author":"Loane","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","article-title":"Astrocyte roles in traumatic brain injury","volume":"275","author":"Burda","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12028-014-0062-0","article-title":"Normobaric hyperoxia is associated with increased cerebral excitotoxicity after severe traumatic brain injury","volume":"22","author":"Quintard","year":"2015","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.lfs.2022.121352_bb0110","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s12035-014-8752-3","article-title":"Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury","volume":"51","author":"Abdul-Muneer","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.121352_bb0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jcp.24830","article-title":"Alphasynuclein as a pathological link between chronic traumatic brain injury and Parkinson\u2019s disease","volume":"230","author":"Acosta","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.121352_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fneur.2013.00030","article-title":"Microglia activation as a biomarker for traumatic brain injury","volume":"4","author":"Hernandez-Ontiveros","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a04a7468-d105-42f3-ba47-263ea2864681","article-title":"Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model","volume":"8","author":"Acosta","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2022.121352_bb0130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/neu.2012.2578","article-title":"Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example","volume":"30","author":"Niyonkuru","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0135","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2741\/4426","article-title":"Traumatic brain injury: a review of characteristics, molecular basis and management","volume":"21","author":"Wang","year":"2016","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jnr.20292","article-title":"Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?","volume":"79","author":"Sullivan","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2022.121352_bb0145","article-title":"Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin a analog","volume":"11","author":"Mbye","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0150","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","article-title":"Molecular and cellular mechanisms of excitotoxic neuronal death","volume":"15","author":"Wang","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.lfs.2022.121352_bb0155","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1476-5381.2012.02025.x","article-title":"Mitochondria in traumatic brain injury and mitochondrial- targeted multipotential therapeutic strategies","volume":"167","author":"Cheng","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121352_bb0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jss.2013.08.027","article-title":"Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury","volume":"186","author":"Wang","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.lfs.2022.121352_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/rda.12230","article-title":"Oxidative stress in neonatology: a review","volume":"49","author":"Mutinati","year":"2014","journal-title":"Reprod. Domest. Anim."},{"key":"10.1016\/j.lfs.2022.121352_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/auto.5.3.8174","article-title":"p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum","volume":"5","author":"Zhang","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2022.121352_bb0175","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/ejn.14307","article-title":"The overlooked aspect of excitotoxicity: glutamate-independent excitotoxicity in traumatic brain injuries","volume":"49","author":"Tehse","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0180","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/antiox10050818","article-title":"Hidrox\u00ae roles in neuroprotection: biochemical links between traumatic brain injury and Alzheimer\u2019s disease","volume":"10","author":"Cordaro","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2022.121352_bb0185","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/antiox10060898","article-title":"Hericium erinaceus and coriolus versicolor modulate molecular and biochemical changes after traumatic brain injury","volume":"10","author":"D\u2019Amico","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2022.121352_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/msj.20104","article-title":"Pathophysiology of traumatic brain injury","volume":"76","author":"Greve","year":"2009","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.brainresrev.2004.12.028","article-title":"Closed head injury\u2014an inflammatory disease?","volume":"48","author":"Schmidt","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.lfs.2022.121352_bb0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-0173(94)00015-H","article-title":"Microglia: intrinsic immuneffector cell of the brain","volume":"20","author":"Gehrmann","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.lfs.2022.121352_bb0220","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.121352_bb0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2022.121352_bb0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-5728(99)00148-4","article-title":"IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function","volume":"101","author":"Csuka","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0240","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","article-title":"Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice","volume":"192","author":"Fluiter","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0245","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/08977150152725605","article-title":"Complement activation in the human brain after traumatic head injury","volume":"18","author":"Bellander","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2016.09.027","article-title":"Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?","volume":"60","author":"Collins-Praino","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2022.121352_bb0255","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40478-016-0382-8","article-title":"Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy","volume":"4","author":"Cherry","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2022.121352_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2013an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2022.121352_bb0265","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/156652401509151105130628","article-title":"Phagoptosis - cell death by phagocytosis - plays central roles in physiology, host defense and pathology","volume":"15","author":"Brown","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2015.02.009","article-title":"A review of the neuro- and systemic inflammatory responses in post concussion symptoms: introduction of the \u201cpost-inflammatory brain syndrome\u201d PIBS","volume":"46","author":"Rathbone","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2022.121352_bb0275","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2022.121352_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-016-0786-1","article-title":"Inflammation in epileptogenesis after traumatic brain injury","volume":"14","author":"Webster","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2022.121352_bb0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1208\/s12248-016-0027-7","article-title":"Microdialysis monitoring in clinical traumatic brain injury and its role in neuroprotective drug development","volume":"19","author":"Thelin","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.lfs.2022.121352_bb0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fneur.2017.00331","article-title":"Cerebrospinal fluid and microdialysis cytokines in severe traumatic brain injury: a scoping systematic review","volume":"8","author":"Zeiler","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0295","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/02699050701311125","article-title":"Increased serum sFas and TNFalpha following isolated severe head injury in males","volume":"21","author":"Crespo","year":"2007","journal-title":"Brain Inj."},{"key":"10.1016\/j.lfs.2022.121352_bb0300","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/shk.0b013e318123e64e","article-title":"Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma","volume":"28","author":"Maier","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2022.121352_bb0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.shk.0000223127.41641.f4","article-title":"Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury","volume":"26","author":"Maier","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2022.121352_bb0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/neu.2007.0405","article-title":"Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury","volume":"25","author":"Chiaretti","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094370","article-title":"Association between serum tissue inhibitor of matrix metalloproteinase- 1 levels and mortality in patients with severe brain trauma injury","volume":"9","author":"Lorente","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121352_bb0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13054-015-0911-z","article-title":"Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury","volume":"19","author":"Lorente","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.lfs.2022.121352_bb0325","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2022.121352_bb0330","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1002\/jcp.26287","article-title":"Inflammasome: its role in traumatic brain and spinal cord injury","volume":"233","author":"Mortezaee","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2022.121352_bb0335","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2022.121352_bb0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","article-title":"Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1","volume":"24","author":"Sutterwala","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2022.121352_bb0345","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1007\/s11064-013-1115-z","article-title":"Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model","volume":"38","author":"Liu","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2022.121352_bb0350","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/dneu.22409","article-title":"High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring","volume":"77","author":"Maturana","year":"2017","journal-title":"Dev Neurobiol."},{"key":"10.1016\/j.lfs.2022.121352_bb0355","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2022.121352_bb0360","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11302-017-9579-y","article-title":"Inhibition of P2X7 receptors improves outcomes after traumatic brain injury in rats","volume":"13","author":"Liu","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.lfs.2022.121352_bb0365","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.bbrc.2018.08.089","article-title":"The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury","volume":"503","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2022.121352_bb0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2022.121352_bb0375","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2022.121352_bb0380","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.4049\/jimmunol.1100790","article-title":"The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release","volume":"187","author":"Hoegen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0385","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0390","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2022.121352_bb0395","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fneur.2018.00135","article-title":"Inflammasome proteins as biomarkers of multiple sclerosis","volume":"9","author":"Keane","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0400","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia."},{"key":"10.1016\/j.lfs.2022.121352_bb0405","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1089\/ars.2014.6126","article-title":"Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit","volume":"22","author":"Mohamed","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2022.121352_bb0410","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1100613","article-title":"Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome","volume":"187","author":"Bauernfeind","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0415","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbi.2015.10.009","article-title":"The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: a role for the NLRP3 inflammasome","volume":"55","author":"Frank","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2022.121352_bb0420","doi-asserted-by":"crossref","first-page":"20388","DOI":"10.1073\/pnas.0908698106","article-title":"Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome","volume":"106","author":"Iyer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.121352_bb0425","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.4049\/jimmunol.1800505","article-title":"Cutting edge: the heat shock protein gp96 activates inflammasome-signaling platforms in APCs","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0430","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0435","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2022.121352_bb0440","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.121352_bb0445","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1402658","article-title":"K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling","volume":"194","author":"Katsnelson","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0450","doi-asserted-by":"crossref","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.121352_bb0455","first-page":"414","article-title":"ATP release and purinergic signaling in NLRP3 inflammasome activation","volume":"3","author":"Gombault","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0460","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0465","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2022.121352_bb0470","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cr.2011.20","article-title":"Mitochondrial ROS fuel the inflammasome","volume":"21","author":"Sorbara","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2022.121352_bb0475","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0480","doi-asserted-by":"crossref","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","article-title":"The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18","volume":"30","author":"Jha","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0485","doi-asserted-by":"crossref","first-page":"447S","DOI":"10.1093\/ajcn\/83.2.447S","article-title":"Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process","volume":"83","author":"Dinarello","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2022.121352_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210128","article-title":"Inflammasome proteins as biomarkers of traumatic brain injury","volume":"13","author":"Kerr","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2022.121352_bb0495","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000354764","article-title":"Increased levels of serum IL-18 are associated with the long-term outcome of severe traumatic brain injury","volume":"21","author":"Ciaramella","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.lfs.2022.121352_bb0500","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fphys.2014.00352","article-title":"Reactive oxygen species at the crossroads of inflammasome and inflammation","volume":"5","author":"Harijith","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2022.121352_bb0505","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm6050055","article-title":"The role of Interleukin-18, oxidative stress and metabolic syndrome in Alzheimer\u2019s disease","volume":"6","author":"Ojala","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04440.x","article-title":"The NLRP3 inflammasome in health and disease: the good, the bad and the ugly","volume":"166","author":"Menu","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2022.121352_bb0515","first-page":"99","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0520","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/neu.2017.5344","article-title":"MCC950, the selective inhibitor of nucleotide oligomerization domain-like receptor protein-3 inflammasome, protects mice against traumatic brain injury","volume":"35","author":"Ismael","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.lfs.2022.121352_bb0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","article-title":"Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury","volume":"117","author":"Xu","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.121352_bb0530","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s10753-016-0446-8","article-title":"Propofol inhibits NLRP3 inflammasome and attenuates blast-induced traumatic brain injury in rats","volume":"39","author":"Ma","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2022.121352_bb0535","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","article-title":"Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury","volume":"36","author":"Wei","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.lfs.2022.121352_bb0540","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2017.01.005","article-title":"Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury","volume":"290","author":"Lin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2022.121352_bb0545","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainres.2019.01.005","article-title":"Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI","volume":"1710","author":"Chen","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2022.121352_bb0550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12028-017-0378-7","article-title":"Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children","volume":"27","author":"Wallisch","year":"2017","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.lfs.2022.121352_bb0555","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/PCC.0000000000000400","article-title":"Cerebrospinal fluid markers of macrophage and lymphocyte activation after traumatic brain injury in children","volume":"16","author":"Newell","year":"2015","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0560","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.jcbfm.9600088","article-title":"Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse","volume":"25","author":"Satchell","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2022.121352_bb0565","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.shk.0000161385.62758.24","article-title":"Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury","volume":"23","author":"Shiozaki","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2022.121352_bb0570","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/jcbfm.2010.142","article-title":"The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production","volume":"31","author":"Helmy","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2022.121352_bb0575","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fnmol.2018.00309","article-title":"Inflammasome proteins in serum and serum-derived extracellular vesicles as biomarkers of stroke","volume":"11","author":"Kerr","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2022.121352_bb0580","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14728210902769601","article-title":"Emerging treatments for traumatic brain injury","volume":"14","author":"Xiong","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.lfs.2022.121352_bb0585","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/antiox9040297","article-title":"Management of traumatic brain injury: from present to future","volume":"9","author":"Crupi","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2022.121352_bb0590","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.3390\/ijms21176204","article-title":"The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury","volume":"21","author":"Irrera","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.lfs.2022.121352_bb0595","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fphar.2017.00459","article-title":"Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury","volume":"8","author":"Irrera","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121352_bb0600","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2017.04.021","article-title":"Mangiferin attenuates blast-induced traumatic brain injury via inhibiting NLRP3 inflammasome","volume":"271","author":"Fan","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.121352_bb0605","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6057609","article-title":"NADPH oxidase 2 regulates NLRP3 inflammasome activation in the brain after traumatic brain injury","volume":"2017","author":"Ma","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2022.121352_bb0610","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180892","article-title":"Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats","volume":"38","author":"Zheng","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2022.121352_bb0615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12974-019-1471-y","article-title":"A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury","volume":"16","author":"Kuwar","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2022.121352_bb0620","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2009.46","article-title":"Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury","volume":"29","author":"de Rivero Vaccari","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2022.121352_bb0625","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.apjtm.2016.01.027","article-title":"Regulating effect of activated NF-kappaB on edema induced by traumatic brain injury of rats","volume":"9","author":"Wang","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.lfs.2022.121352_bb0630","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121352_bb0635","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.lfs.2022.121352_bb0640","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1038\/s41598-018-24350-x","article-title":"Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke","volume":"8","author":"Ismael","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121352_bb0645","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/STROKEAHA.117.018904","article-title":"Selective NLRP3 (pyrin domain-containing protein 3) inflammasome inhibitor reduces brain injury after intracerebral hemorrhage","volume":"49","author":"Ren","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2022.121352_bb0650","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1021\/acs.jmedchem.8b00733","article-title":"Structural insights of benzenesulfonamide analogues as NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization","volume":"61","author":"Fulp","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121352_bb0655","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FJC.0000000000000053","article-title":"A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse","volume":"63","author":"Marchetti","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522010529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522010529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:52:13Z","timestamp":1736333533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522010529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":130,"alternative-id":["S0024320522010529"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121352","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121352"}}